Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.
Conclusion: Remdesivir may show clinical efficacy for the treatment of severe COVID-19 in a community setting. Although this was a small-scale study with limited patients, it represents a point of reference for the use of remdesivir at other community hospitals.
PMID: 33136164 [PubMed - as supplied by publisher]
Source: Journal of the American Osteopathic Association - Category: Complementary Medicine Tags: J Am Osteopath Assoc Source Type: research
More News: Complementary Medicine | Coronavirus | COVID-19 | Dexamethasone | Hypertension | Intensive Care | Liver | Nutrition | Pregnancy | Respiratory Medicine | SARS | Statistics | Study | Urology & Nephrology | Women